Tue, 03 Mar 2020 10:03:22 GMT
Novartis unit agrees to pay $195M to settle antitrust charges
Sandoz, the Novartis unit, agreed to pay $195M to reach thee deferred prosecution deal to resolve antitrust charges, following the 2013-2015 probe into the generic drug industry, the Justice Department stated.